T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Flowers Foods
FLO
$1.59B
| $260M | 0.03% |
10,946,257
-906,388
| -8% | -$20.7M |
|
377
Palo Alto Networks
PANW
$323B
| $259M | 0.03% |
1,821,444
-348,256
| -16% | -$54.9M |
|
378
Coinbase
COIN
$39.9B
| $258M | 0.03% |
974,543
-367,496
| -27% | -$66.1M |
|
379
CubeSmart
CUBE
$9.42B
| $257M | 0.03% |
5,687,536
+1,205,097
| +27% | +$53.4M |
|
380
Service Corp International
SCI
$11.5B
| $257M | 0.03% |
3,461,113
-385,276
| -10% | -$27.2M |
|
381
Kymera Therapeutics
KYMR
$9.41B
| $255M | 0.03% |
6,332,012
+996,300
| +19% | +$35.6M |
|
382
APi Group
APG
$18.7B
| $253M | 0.03% |
9,664,973
+2,739,341
| +40% | +$63.7M |
|
383
Neurocrine Biosciences
NBIX
$15.3B
| $251M | 0.03% |
1,820,796
+343,847
| +23% | +$47M |
|
384
FTI Consulting
FCN
$4.24B
| $250M | 0.03% |
1,187,469
+35,599
| +3% | +$7.15M |
|
385
Starbucks
SBUX
$125B
| $250M | 0.03% |
2,730,742
-287,517
| -10% | -$26.7M |
|
386
SS&C Technologies
SSNC
$19B
| $248M | 0.03% |
3,860,256
+25,183
| +0.7% | +$1.56M |
|
387
BP
BP
$109B
| $246M | 0.03% |
6,515,539
+397,153
| +6% | +$14.2M |
|
388
CAVA Group
CAVA
$8.43B
| $243M | 0.03% |
3,470,949
-786,078
| -18% | -$42.1M |
|
389
Ventas
VTR
$46.2B
| $239M | 0.03% |
5,489,159
+413,564
| +8% | +$18.8M |
|
390
Carrier Global
CARR
$51.8B
| $234M | 0.03% |
4,033,941
-10,787,341
| -73% | -$606M |
|
391
Middleby
MIDD
$5.37B
| $233M | 0.03% |
1,450,221
+11,552
| +0.8% | +$1.7M |
|
392
OneMain Financial
OMF
$7.47B
| $233M | 0.03% |
4,558,077
-12,225
| -0.3% | -$584K |
|
393
Seadrill
SDRL
$2.89B
| $233M | 0.03% |
4,623,308
+499,437
| +12% | +$22.7M |
|
394
Celsius Holdings
CELH
$7.13B
| $232M | 0.03% |
2,802,264
+9,054
| +0.3% | +$621K |
|
395
RH
RH
$3.52B
| $232M | 0.03% |
665,383
+62,198
| +10% | +$17M |
|
396
Illinois Tool Works
ITW
$82.9B
| $232M | 0.03% |
862,761
-82,354
| -9% | -$21.4M |
|
397
Mattel
MAT
$4.25B
| $231M | 0.03% |
11,685,291
+180,855
| +2% | +$3.43M |
|
398
ICICI Bank
IBN
$106B
| $228M | 0.03% |
8,621,161
-619,346
| -7% | -$15.5M |
|
399
3M
MMM
$94.1B
| $225M | 0.03% |
2,542,384
-870,211
| -25% | -$72.2M |
|
400
Alkermes
ALKS
$8.33B
| $225M | 0.03% |
8,326,256
+6,730,671
| +422% | +$191M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.